Jose-Luis Diaz-Ortega

Personal information Occupation: Researcher of Medical Sciences. Instituto Nacional de Salud Pública. Office adress: Av. Universidad 655. Col. Sta. Ma. Ahuacatitlan Cuernavaca, Morelos.C.P. 62100, México Telephone number: Office: +52777 329 3000 Movil: +52 777- 30747-39 Email: jdiaz@insp.mx Eductaion - Medical Doctor. National Autonomous University of Mexico. - Specialist of Epidemiology. National Institute of Public Health (INSP). - Specialist of Immunology. National Polythecnic Institute. - Diploma of Physical Anthropology. National School of Anthropology. - Diploma of Teaching in Higher Education. INSP. - Diploma of Economic Evaluation of Health Interventions. INSP. Job and research experience. 1. Current job. Researcher in Medical Sciences, and Professor of the summer course: “Vaccines and Public Health”, and other courses related to epidemiological surveillance, and management of public health programs. Assistant professor of different courses of the Master of Public Health. Investigator of alternative routes for immunization (aerosolized MMR Vaccines), barriers and missed opportunities for immunization, and transmission patterns of different vaccine preventable diseases. 2. Consultancy activities (vaccine preventable diseases) Since 1992: - Mexico, Costa Rica (PAHO), India (WHO), Myanmar (WHO), Sri Lanka (WHO), United States of America (PAHO), Dominican Republic (PAHO) Publications (1995-2013) 1. Mongua-Rodriguez, Díaz-Ortega JL, García-García L, Piña-Pozas M, Ferreira-Guerrero E, et al. A systematic review of rubella vaccination strategies implemented in the Americas: impact on the incidence and seroprevalence rates of rubella and congenital rubella syndrome. Vaccine 2013; 31: 2145-2151. 2. Díaz‐Ortega JL, Ferreira‐Guerrero E, Trejo‐Valdivia B, Téllez Rojo MM, et al. Cobertura de vacunación en niños y adolescentes en México: vacunados, subvacunados y no vacunados. Salud Pública Mex 2013; 55 (supl 2):S289-S299. 3. Ferreira Guerrero E, Mongua‐Rodríguez N, Díaz‐Ortega JL, Delgado‐Sánchez G, et al. Diarreas agudas y prácticas de alimentación en niños menores de 5 años. Salud Pública Mex 2013; 55 (supl 2):S300-S306. 4. Cruz-Hervert LP, Ferreira-Guerrero E, Díaz Ortega JL, et al. Vacunación en adultos y adultos mayores en México. Un reto al Programa de Vacunación. Salud Pública Mex 2013; 55 (supl 2):S314-S322. 5. Díaz-Ortega JL, Bennett JV, Castañeda D, Martinez D, Fernandez de Castro J. Aerosolized MMR vaccine: evaluating potential transmission of components to vaccine administrators and contacts of vaccinees. Biologicals 2012; 40(4):278-81. 6. Díaz-Ortega JL, Bennett JV, Castañeda D, Arellano D, Martinez D, Fernandez de Castro J. Safety and antibody responses to aerosolized MMR II vaccine in adults: An exploratory study. World Journal of Vaccines 2012 2:55-60. 7. Díaz-Ortega JL, Bennett JV, Castañeda D, Martinez D, Fernandez de Castro J. Antibody persistence in young adults 1 year after MMR immunization by aerosol or by subcutaneous route. Vaccine 2010; 28:7228-7232. 8. Diaz-Ortega JL, Bennett JV, Castañeda D, Valdespino-Gomez JL, Fernandez de Castro J. Successful seroresponses to measles and rubella following aerosolized Triviraten vaccine, but poor response to aerosolized mumps (Rubini) component: Comparisons with injected MMR. Vaccine 2010; 28:692-698 9. Diaz-Ortega JL, Meneses-Reyes CD, Palacios-Martínez M. Incidencia y patrones de transmisión de rubeola en México. Salud Publica Mex 2007; 49:337-344 10. Acharya A, Diaz-Ortega JL, Tambini G, De Quadros C, Arita I. Cost-effectiveness of measles elimination in Latin America and Caribbean: a prospective analysis. Vaccine 2002; 20:3332-3341 11. Badilla Vargas Xiomara, Saénz Elizabeth, Machado Vicenta, Diaz Ortega josé Luis. Investigación de brote de Enfermedad Febril Eruptiva en Vainilla, Península de Nicoya, 1 enero al 15 de marzo 2001. Costa Rica. http://desastres.cies.edu.ni/digitaliza/tesis/t95/seccionb.pdf 12. Ferreira E, Carrion V, Lucas CA, Kuri P, Flisser A, Diaz-Ortega JL, et al. Rubella and congenital rubella sindrome. United States and Mexico, 1997-1999. MMWR 2000; 49 (46):1048-1050, 1059 13. González DA, Vargas MMR, Hernández OM, Ruiz MC, Diaz-Ortega JL, et al. Características epidemiológicas de la tosferina en condiciones de baja cobertura de vacunación. ComSalud 1998; 31-38 14. Ruiz Matus C, Diaz Ortega JL, Valdés Hernández J. Supervisión integral. Epidemiología. 1997; 14 (44):1-3 15. Cuts FT, Robertson SE, Diaz OJL, Samuel R. Control of rubella and congenital rubella sindrome (CRS) in developing countries, part 1: burden of disease from CRS. Bulletin of the World Health Organization 1997; 75:55-68 16. Robertson SE, Cuts FT, Samuel R, Diaz OJL. Control of rubella and congenital rubella sindrome (CRS) in developing countries, part 2: vaccination against rubella. Bulletin of the World Health Organization 1997; 75:69-80 22 articles more, from 1985-1994.